EFFECTS OF IMMUNE CHECKPOINT THERAPY ON LATENT HIV IN PEOPLE WITH HIV AND MALIGNANCY
Immune checkpoint blockade (ICB) is highly effective for the management of some malignancies and can potentially perturb HIV persistence in people living with HIV (PLWH) on antiretroviral therapy (ART) by enhancing HIV-specific CD8+ T cells and/or reversing HIV latency. We established a prospective cohort of PLWH on ART with malignancy who received any ICB and…